Black Diamond Therapeutics, Inc. (BDTX) Stock Analysis & Investment Frameworks
Black Diamond Therapeutics, Inc. (BDTX) stock analysis on Invetso. Review Black Diamond Therapeutics, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Black Diamond Therapeutics, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Black Diamond Therapeutics, Inc. Key Financial Metrics
- Market Cap: $118.61M
- Revenue: $70.00M
- P/E Ratio: 5.31
- ROE: -38.80%
- ROIC: -45.91%
- Dividend Yield: N/A
About Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) driver mutations. The firm is also progressing BDTX-1535, a brain-penetrant inhibitor addressing a range of EGFR mutations, including conventional, inherent resistance, and acquired resistance forms. Concurrently, it is advancing BDTX-4933, another brain-penetrant inhibitor targeting oncogenic BRAF alterations across Class I, II, and III categories. Black Diamond maintains a strategic alliance with OpenEye Scientific Software, Inc. Established in 2014, the company was initially known as ASET Therapeutics, Inc. before adopting its current name, Black Diamond Therapeutics, Inc., in January 2018. Its corporate headquarters are situated in Cambridge, Massachusetts.
Black Diamond Therapeutics, Inc. Investment Frameworks
Invetso analyzes Black Diamond Therapeutics, Inc. (BDTX) across the following frameworks:
- Black Diamond Therapeutics, Inc. 10Y Growth Potential
- Black Diamond Therapeutics, Inc. Scenario Analysis
- Black Diamond Therapeutics, Inc. Risks & Opportunities
- Black Diamond Therapeutics, Inc. Economic Moat
- Black Diamond Therapeutics, Inc. Business Model
- Black Diamond Therapeutics, Inc. Management
- Black Diamond Therapeutics, Inc. SWOT Analysis
- Black Diamond Therapeutics, Inc. Porter's 5 Forces
- Black Diamond Therapeutics, Inc. PESTLE Analysis
- Black Diamond Therapeutics, Inc. ESG Analysis